Cell-free inhibition of EGFR and HER2 kinases
Biochemical assay · Human wild-type EGFR, EGFR L858R, EGFR L858R/T790M and HER2 kinase domains [1]
BIBW2992 inhibited EGFR variants and HER2 in a comparative enzyme panel. These assay IC50 values do not specify cellular treatment doses or establish covalent binding by themselves.
| Endpoint | Reported result | Reference |
|---|---|---|
| Wild-type EGFR kinase inhibition | IC50 0.5 nM | [1] |
| EGFR L858R kinase inhibition | IC50 0.4 nM | [1] |
| EGFR L858R/T790M kinase inhibition | IC50 10 nM | [1] |
| HER2 kinase inhibition | IC50 14 nM | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Serial inhibitor dilutions; IC50 endpoints reported separately.
- Exposure duration
- 30 min kinase reaction at room temperature (readable supplementary assay text).
- Method
- Kinase activity measured with or without inhibitor; comparator inhibitors included lapatinib, canertinib and gefitinib.
- Vehicle
- Inhibitor dilutions prepared in 50% Me2SO; this is the dilution solvent, not the final assay percentage.
- Reported limits
- Exact tested concentration series and numerical independent-experiment count are not specified in Table 1. Full supplement not parsed; no wider selectivity claim adopted.
Methods and source locations
Compound reported in the paper: Afatinib; Compound label in the paper: BIBW2992
Compound-level evidence; no salt conversion, catalog-number match or current Adooq lot validation is established.
Table 1 and its footnote; Results: BIBW2992 inhibits EGFR and HER2 kinase activity in vitro; Methods: Synthesis of compounds and In vitro kinase activity assays
Wild-type EGFR kinase inhibition: Cell-free kinase assay with pEY substrate; Table 1 states independent confirmation, without a numerical experiment count or uncertainty. — Table 1, BIBW2992 column and footnote
EGFR L858R kinase inhibition: Cell-free kinase assay with pEY substrate; Table 1 states independent confirmation, without a numerical experiment count or uncertainty. — Table 1, BIBW2992 column and footnote
EGFR L858R/T790M kinase inhibition: Cell-free kinase assay with pEY substrate; Table 1 states independent confirmation, without a numerical experiment count or uncertainty. — Table 1, BIBW2992 column and footnote
HER2 kinase inhibition: Cell-free kinase assay with pEY substrate; Table 1 states independent confirmation, without a numerical experiment count or uncertainty. — Table 1, BIBW2992 column and footnote